Masimo scored in 2014 with huge gains in both product revenue and net income.
Masimo (NSDQ:MASI), reported double-digit growth in sales and solid gains in net income during the final quarter of 2014.
Officials at the Irvine, Calif. -based patient monitoring company said they expect that growth to continue into 2015, even though foreign exchange rates will take a bite out of revenue over the coming year.
Medical device executives and Rep. Erik Paulsen (R-Minn.) scoff at a government report saying the levy's impact will be limited, telling MassDevice.com they're more confident than ever about repealing the medical device tax.
Medtech executives last week bashed a newly updated report from the Congressional Research Service refuting claims that the medical device tax kills jobs and hampers innovation.
An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.
MassDevice.com publisher Brian Johnson sat down with Masimo (NSDQ:MASI) CEO Joe Kiani at DeviceTalks West in Irvine, Calif., On Nov. 19 for a wide-ranging interview about patient safety, corporate culture and the company's 25th anniversary.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?: J&J demands $7.2 billion from Boston Scientific as trial begins; Will Orange County's medtech scene lose its juice without Allergan?; BD-CareFusion deal passes US anti-trust waiting period; Sources: Stryker weighs bid for Smith & Nephew
, Becton Dickinson & Co.
, Boston Scientific
, CareFusion Corp.
, Guidant Corp.
, Johnson & Johnson
, Smith & Nephew
, Valeant Pharmaceuticals
, Allergan Inc.
Will the $66 billion buyout of Allergan by Actavis suck some of the juice out of Orange County, Calif., which Allergan's called home for 60 years?
Pioneering live interview series from MassDevice.com will close its 2014 season this week in Irvine, Calif. with Masimo CEO Joe Kiani and Caroll Neubauer, CEO, B. Braun Medical.
DeviceTalks, the live interview series featuring thought leaders from the $126B medical technology industry, closes out its 2014 season on November 19, 2014 in Irvine, Calif. with a conversation focused on whether the medical device industry is doing enough to protect patients.
In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.